Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2018-10, Vol.29 Suppl 8, p.viii189 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | viii189 |
container_title | Annals of oncology |
container_volume | 29 Suppl 8 |
creator | Goel, S Ocean, A Parakrama, R Ghalib, M H Chaudhary, I Shah, U Coffey, M Kaledzi, E Maitra, R |
description | |
doi_str_mv | 10.1093/annonc/mdy281.111 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy281_111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32136367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1781-bfb85153683de1f6f49e40da3ab364ee9ec5b91d4d944886112a21fa30237d0e3</originalsourceid><addsrcrecordid>eNo9kcGO0zAURS0EYsrAB7BBb9kuMvGLkzRhNxQKFZVGKrCOHPsZjBK7sp2i8nl8GUEBVk-6V-e-xWHsJfI75K3IpXPeqXzU16LBO0R8xFZY1W3W8BIfsxVvC5FtK1HesGcxfuec123RPmU3okBRi3q7Yr_e-khgrNPWfQXpNERpKF0hpklfwRsI5C82TBHWJ_Ib-GHTN7DBOp9ISZeDGSYf_BSkskMOA03KX_zc59DTZQ5_TqPsYb1_OO4Pp0P-ZgPWwVkmSy7FZe7j6f4TjFOSLsFIScY01wqUH3wgleQA8ydFAdbj7rTbvIa9dXMYKE5Dis_ZEyOHSC_-3lv2Zf_u8-5Ddnx4f9jdHzOF2waz3vRNhZWoG6EJTW3KlkqupZC9qEuillTVt6hL3ZZl09SIhSzQSMELsdWcxC3DZVcFH2Mg052DHWW4dsi7Pz66xUe3-OhmHzPzamHOUz-S_k_8EyB-A9Zqi6Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Goel, S ; Ocean, A ; Parakrama, R ; Ghalib, M H ; Chaudhary, I ; Shah, U ; Coffey, M ; Kaledzi, E ; Maitra, R</creator><creatorcontrib>Goel, S ; Ocean, A ; Parakrama, R ; Ghalib, M H ; Chaudhary, I ; Shah, U ; Coffey, M ; Kaledzi, E ; Maitra, R</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy281.111</identifier><identifier>PMID: 32136367</identifier><language>eng</language><publisher>England</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii189</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32136367$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goel, S</creatorcontrib><creatorcontrib>Ocean, A</creatorcontrib><creatorcontrib>Parakrama, R</creatorcontrib><creatorcontrib>Ghalib, M H</creatorcontrib><creatorcontrib>Chaudhary, I</creatorcontrib><creatorcontrib>Shah, U</creatorcontrib><creatorcontrib>Coffey, M</creatorcontrib><creatorcontrib>Kaledzi, E</creatorcontrib><creatorcontrib>Maitra, R</creatorcontrib><title>Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo9kcGO0zAURS0EYsrAB7BBb9kuMvGLkzRhNxQKFZVGKrCOHPsZjBK7sp2i8nl8GUEBVk-6V-e-xWHsJfI75K3IpXPeqXzU16LBO0R8xFZY1W3W8BIfsxVvC5FtK1HesGcxfuec123RPmU3okBRi3q7Yr_e-khgrNPWfQXpNERpKF0hpklfwRsI5C82TBHWJ_Ib-GHTN7DBOp9ISZeDGSYf_BSkskMOA03KX_zc59DTZQ5_TqPsYb1_OO4Pp0P-ZgPWwVkmSy7FZe7j6f4TjFOSLsFIScY01wqUH3wgleQA8ydFAdbj7rTbvIa9dXMYKE5Dis_ZEyOHSC_-3lv2Zf_u8-5Ddnx4f9jdHzOF2waz3vRNhZWoG6EJTW3KlkqupZC9qEuillTVt6hL3ZZl09SIhSzQSMELsdWcxC3DZVcFH2Mg052DHWW4dsi7Pz66xUe3-OhmHzPzamHOUz-S_k_8EyB-A9Zqi6Y</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Goel, S</creator><creator>Ocean, A</creator><creator>Parakrama, R</creator><creator>Ghalib, M H</creator><creator>Chaudhary, I</creator><creator>Shah, U</creator><creator>Coffey, M</creator><creator>Kaledzi, E</creator><creator>Maitra, R</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results</title><author>Goel, S ; Ocean, A ; Parakrama, R ; Ghalib, M H ; Chaudhary, I ; Shah, U ; Coffey, M ; Kaledzi, E ; Maitra, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1781-bfb85153683de1f6f49e40da3ab364ee9ec5b91d4d944886112a21fa30237d0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goel, S</creatorcontrib><creatorcontrib>Ocean, A</creatorcontrib><creatorcontrib>Parakrama, R</creatorcontrib><creatorcontrib>Ghalib, M H</creatorcontrib><creatorcontrib>Chaudhary, I</creatorcontrib><creatorcontrib>Shah, U</creatorcontrib><creatorcontrib>Coffey, M</creatorcontrib><creatorcontrib>Kaledzi, E</creatorcontrib><creatorcontrib>Maitra, R</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goel, S</au><au>Ocean, A</au><au>Parakrama, R</au><au>Ghalib, M H</au><au>Chaudhary, I</au><au>Shah, U</au><au>Coffey, M</au><au>Kaledzi, E</au><au>Maitra, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29 Suppl 8</volume><spage>viii189</spage><pages>viii189-</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pmid>32136367</pmid><doi>10.1093/annonc/mdy281.111</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii189 |
issn | 0923-7534 1569-8041 |
language | eng |
recordid | cdi_crossref_primary_10_1093_annonc_mdy281_111 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
title | Dose finding and safety study of reovirus (Reo) with irinotecan/ fluorouracil/ leucovorin/ bevacizumab (FOLFIRI/B) in patients with KRAS mutant metastatic colorectal cancer (mCRC): Final results |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T00%3A51%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dose%20finding%20and%20safety%20study%20of%20reovirus%20(Reo)%20with%20irinotecan/%20fluorouracil/%20leucovorin/%20bevacizumab%20(FOLFIRI/B)%20in%20patients%20with%20KRAS%20mutant%20metastatic%20colorectal%20cancer%20(mCRC):%20Final%20results&rft.jtitle=Annals%20of%20oncology&rft.au=Goel,%20S&rft.date=2018-10&rft.volume=29%20Suppl%208&rft.spage=viii189&rft.pages=viii189-&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy281.111&rft_dat=%3Cpubmed_cross%3E32136367%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32136367&rfr_iscdi=true |